Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the legal status of telemedicine abortion services in the US by end of 2025?
Nationally restricted • 25%
Allowed in some states • 25%
Nationally allowed • 25%
Status quo remains • 25%
Federal and state court decisions, legislative actions
Texas AG Paxton Sues NY Doctor in First Challenge to Shield Law Over Abortion Pills
Dec 13, 2024, 08:22 PM
Texas Attorney General Ken Paxton has filed a lawsuit against a New York doctor, accusing her of illegally prescribing and mailing abortion pills to a Texas woman in violation of Texas state law, including the Human Life Protection Act. The lawsuit alleges that the doctor provided the medication via telemedicine, leading the woman to seek emergency medical care. This case marks Texas's first legal action against an out-of-state abortion provider and the first challenge to shield laws enacted by Democratic-controlled states like New York, which aim to protect doctors from out-of-state prosecution. The lawsuit underscores Paxton's ongoing efforts to further restrict abortion access in Texas and sets the stage for a significant legal battle over interstate telemedicine and conflicting state abortion laws.
View original story
Introduce new federal law • 25%
Issue federal guidance • 25%
No action • 25%
Challenge state laws • 25%
Yes • 50%
No • 50%
No change • 25%
Mixed outcomes • 25%
Looser regulations • 25%
Stricter regulations • 25%
Missouri • 25%
Florida • 25%
Texas • 25%
Other • 25%
Equal usage of pills and surgery • 25%
Other methods • 25%
Surgical procedures • 25%
Abortion pills • 25%
No action taken • 25%
Amendment passed • 25%
Amendment failed • 25%
Amendment delayed • 25%
Indifferent/No opinion • 25%
Majority approval • 25%
Majority disapproval • 25%
Mixed opinions • 25%
Other • 25%
Not passed • 25%
Passed but blocked • 25%
Passed and enacted • 25%
Unrestricted as per Amendment 3 • 25%
Fully restricted • 25%
In legal limbo • 25%
Partially restricted • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
21 to 30 • 25%
More than 30 • 25%
Less than 10 • 25%
10 to 20 • 25%